Junyi Li
Impact in
-
- Cancer, Lipids, and Metabolism
- Cancer-related molecular mechanisms research
Papers in
-
- Inflammasome and immune disorders 3
- Oncology 11
- Cytokine Signaling Pathways and Interactions 4
- Drug Transport and Resistance Mechanisms 4
- Co-authors
- Haifeng Zhou (15 shared papers)Fei Sun (12 shared papers)Allan R. Brasier (2 shared papers)Heng Fan (10 shared papers)Desheng Hu (11 shared papers)Faxi Wang (3 shared papers)Jia Yang (5 shared papers)Alexey Sarapultsev (4 shared papers)
In The Last Decade
Junyi Li
31 papers receiving 822 citations
Junyi Li's Hit Papers
Peers
Comparison fields: 5 of 105
- Biological Psychiatry 22
- Cancer Research 111
- Pharmacology 61
- Molecular Medicine 32
- Immunology 131
Countries citing papers authored by Junyi Li
This map shows the geographic impact of Junyi Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junyi Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junyi Li more than expected).
Fields of papers citing papers by Junyi Li
This network shows the impact of papers produced by Junyi Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junyi Li. The network helps show where Junyi Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Junyi Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Berberine ameliorates DSS-induced intestinal mucosal barrier dysfunction through microbiota-dependence and Wnt/β-catenin pathway Hit paper breakdown → | 2022 | 116 |
| 2 | Timosaponin AIII promotes non-small-cell lung cancer ferroptosis through targeting and facilitating HSP90 mediated GPX4 ubiquitination and degradation Hit paper breakdown → | 2023 | 113 |
| 3 | 1996 | 82 | |
| 4 | 2020 | 51 | |
| 5 | 2022 | 49 | |
| 6 | 2022 | 49 | |
| 7 | 2022 | 37 | |
| 8 | 2019 | 32 | |
| 9 | 2020 | 31 | |
| 10 | 2023 | 29 | |
| 11 | 2018 | 28 | |
| 12 | 2021 | 25 | |
| 13 | 2021 | 25 | |
| 14 | 2019 | 24 | |
| 15 | 1994 | 24 | |
| 16 | 2021 | 18 | |
| 17 | 2024 | 16 | |
| 18 | 2021 | 16 | |
| 19 | 2022 | 13 | |
| 20 | 2020 | 13 |
About Junyi Li
Junyi Li is a scholar working on Molecular Biology, Oncology, Immunology, Cancer Research and Epidemiology, having authored 32 papers that have together received 837 indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (4 papers), Inflammatory Bowel Disease (4 papers), Drug Transport and Resistance Mechanisms (4 papers), Cancer, Lipids, and Metabolism (3 papers), Inflammasome and immune disorders (3 papers), Hepatitis B Virus Studies (2 papers), Immune Cell Function and Interaction (2 papers) and Immunotherapy and Immune Responses (2 papers). The work is most often cited by research in Biological Psychiatry (22 citations), Cancer Research (111 citations), Pharmacology (61 citations), Molecular Medicine (32 citations) and Immunology (131 citations). Junyi Li has collaborated with scholars based in China, Hong Kong and Russia. Frequent co-authors include Haifeng Zhou, Fei Sun, Allan R. Brasier, Heng Fan, Desheng Hu, Faxi Wang, Jia Yang, Alexey Sarapultsev, Ge Zhang and Yalan Dong. Their work appears in journals such as Frontiers in Pharmacology, International Journal of Biological Sciences, Scientific Reports, Journal of Leukocyte Biology and Endocrine Connections.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.